Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor
Clinical trial NCT04337606 · UNKNOWN
Trial details
- NCT number
- NCT04337606
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-04
- Primary completion
- 2024-04-04
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.